Surgical resection plus biotherapy/chemotherapy improves survival of hepatic metastatic melanoma

Table 1 General information of the patients with hepatic metastatic melanoma

Case	Age (yr)	Gender	Primary melanoma lesion	Interval time before hepatic metastasis (yr)	Accompanying metastasis	Treatments	Survival time (mo)
1	39	M	Sclerotica	7	Spleen	Hepatectomy + comprehensive treatment	30
2	49	M	Left choroid	16	None	Puncture and biopsy + BCG	4
3	51	F	Rectum	0	Abdominal cavity	Biopsy + supportive therapy	1.5
4	69	M	Right lower eyelid	11	Recurrence of carcinoma in situ; metastasis to right hip	Biopsy + supportive therapy	2
5	68	M	Nasal cavity	0.6	Bilateral lung, pleura and cervical lymph nodes	Biopsy + supportive therapy	1.5
6	61	F	Back	8	None	Hepatectomy + comprehensive treatment	29
7	70	F	Resctum	1.5	Recurrence of carcinoma in situ	Mile’s surgery	14
8	48	M	Right 5th dactylus	0.5	Recurrence of carcinoma in situ	Hepatectomy, resection of primary lesion + comprehensive treatment	33
9	74	M	Sole	9	Inguinal lymph nodes	Hepatectomy	18